ReviewBMC pediatrics2025
De novo CHD7 variant in a CHARGE syndrome preterm infant initially diagnosed as idiopathic hypogonadotropic hypogonadism: a case report and literature review.
Review in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CHARGE syndrome with hypothyroidism: a case report.AME case reports · 2026Article
- Correction: De Novo CHD7 variant in a CHARGE syndrome preterm infant initially diagnosed as idiopathic hypogonadotropic hypogonadism: a case report and literature review.BMC pediatrics · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
backgroundCHARGE syndrome (CS), a rare and complex autosomal dominant disorder characterized by ocular coloboma, cardiac defects, choanal atresia, growth retardation, genital abnormalities, and ear malformations, is caused primarily by variants in the chromodomain helicase DNA-binding protein 7 (CHD7) gene. The clinical manifestations of CS frequently overlap with those of idiopathic hypogonadotropic hypogonadism (IHH), complicating diagnosis and management. To date, only a few cases of preterm infants with CS have been reported. Here, we describe the clinical features and genetic findings of a very preterm male infant who was initially diagnosed with IHH but was ultimately confirmed to have CS, carrying a de novo heterozygous CHD7 variant, highlighting the diagnostic and management challenges associated with this condition. CASE PRESENTATION: A preterm male infant, born at 28 + 2 weeks with a birth weight of 1.15 kg, presented with micropenis and right radial polydactyly. Initial suspicion of IHH arose due to micropenis, cryptorchidism, and low levels of testosterone, LH, and FSH. Despite normal cranial MRI findings, further investigations revealed hsPDA, aortic arch narrowing, renal pelvis separation, and EEG abnormalities. Comprehensive genetic analyses, including whole-exome sequencing (WES), Sanger sequencing, and a Mini-gene Assay, confirmed the presence of a pathogenic de novo splicing variant in the CHD7 gene [c.5405-7G > A (NM_017780.4)]. As dysmorphic features progressed, the diagnosis was revised from IHH to CHARGE syndrome. Despite surgical and supportive treatments, the infant developed CRE sepsis and passed away after the withdrawal of life support.
conclusionsTo our knowledge, this is the first reported case of CS with polydactyly in a very preterm infant at approximately 28 weeks gestation. Furthermore, we summarized the clinical and genetic findings of previously reported cases with overlapping CS and IHH phenotypes. This study expands the clinical phenotypes of CHD7-related disorders and provides new insights into early diagnosis, management, and future research on the relationship between CS and IHH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.